 5. Measurable disease per RECIST 1.1 or bone-only disease with lytic component. Patients with bone-only metastatic cancer must have a lytic or mixed lytic-blastic lesion that can be accurately assessed by computerized tomography CT or magnetic resonance imaging MRI. Patients with bone-only disease without a lytic component ie, blastic-only metastasis are not eligible. 